137 related articles for article (PubMed ID: 1180547)
1. Comparison of cefoxitin and cephalothin therapy of a mixed Bacteroides fragilis and Fusobacterius necrophorum infection in mice.
Hackman AS; Wilkins TD
Antimicrob Agents Chemother; 1975 Aug; 8(2):224-5. PubMed ID: 1180547
[TBL] [Abstract][Full Text] [Related]
2. Penetration of cephalothin and cefoxitin into experimental infections with Bacteroides fragilis.
O'Keefe JP; Tally FP; Barza M; Gorbach SL
Rev Infect Dis; 1979; 1(1):106-12. PubMed ID: 318211
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vivo efficiency of cefamandole and cefoxitin against Bacteroides fragilis.
Bergeron MG; Gauvreau L; Nguyen BM
Scand J Infect Dis Suppl; 1980; suppl 25():60-5. PubMed ID: 6937954
[TBL] [Abstract][Full Text] [Related]
4. [In vitro susceptibility of bacteroidaceae to cefoxitin and cephalothin (author's transl)].
Werner H; Firsching R; Krasemann C
Infection; 1977; 5(1):13-6. PubMed ID: 856727
[TBL] [Abstract][Full Text] [Related]
5. beta-lactamases in bacteroides.
Nord CE; Olsson B; Dornbusch K
Scand J Infect Dis Suppl; 1978; (13):27-32. PubMed ID: 28561
[TBL] [Abstract][Full Text] [Related]
6. In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis.
Hackman AS; Wilkins TD
Antimicrob Agents Chemother; 1975 May; 7(5):698-703. PubMed ID: 1041218
[TBL] [Abstract][Full Text] [Related]
7. Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates.
Bieluch VM; Cuchural GJ; Snydman DR; Gorbach SL; Tally FP
Diagn Microbiol Infect Dis; 1987 Jun; 7(2):119-26. PubMed ID: 3652652
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacies of ticarcillin, ticarcillin/clavulanic acid, piperacillin and cefoxitin against polymicrobial infections in mice caused by Escherichia coli and Bacteroides fragilis.
Beale AS; Gisby J
Infection; 1991; 19(2):101-5. PubMed ID: 2050417
[TBL] [Abstract][Full Text] [Related]
9. The use of intravenous cefoxitin sodium in patients with obstetric/gynaecologic infections.
White JS; Gee C; Ledger WJ
J Antimicrob Chemother; 1978 Jul; 4(B):239-40. PubMed ID: 357395
[No Abstract] [Full Text] [Related]
10. Studies with cefuroxime and cefoxitin.
Geddes AM; McGhie D; Ball AP; Gould I
Scand J Infect Dis Suppl; 1978; (13):78-81. PubMed ID: 308260
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of cephalosporins by Bacteroides.
Tally FP; O'Keefe JP; Sullivan NM; Gorbach SL
Antimicrob Agents Chemother; 1979 Nov; 16(5):565-71. PubMed ID: 525995
[TBL] [Abstract][Full Text] [Related]
12. [Synergistic effect of thiamphenicol and cephalothin on Bacterioides fragilis (author's transl)].
Isono M; Aoki M; Kobayashi T; Marui T; Yamada H; Umemura A; Watanabe K; Ueno K
Jpn J Antibiot; 1981 May; 34(5):647-50. PubMed ID: 7026821
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of moxalactam in an animal model of subcutaneous abscesses: penetration into infected sites and in vivo activity against Bacteroides fragilis.
Bartlett JG; Joiner KA; Dezfulian M; Marien GJ
Rev Infect Dis; 1982; 4 Suppl():S664-9. PubMed ID: 6218580
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of an experimental Bacteroides fragilis infection in mice.
Walker CB; Nitzan D; Wilkins TD
Antimicrob Agents Chemother; 1977 Mar; 11(3):435-40. PubMed ID: 855998
[TBL] [Abstract][Full Text] [Related]
15. Aspects on antibacterial treatment of anaerobic infections.
Nordbring F; Nord CE
Scand J Infect Dis Suppl; 1982; 35():59-62. PubMed ID: 6762654
[TBL] [Abstract][Full Text] [Related]
16. Use of cephalosporins for prophylaxis and therapy of polymicrobial infection in mice.
Brook I
Antimicrob Agents Chemother; 1993 Jul; 37(7):1531-5. PubMed ID: 8363386
[TBL] [Abstract][Full Text] [Related]
17. Therapy for experimental intraabdominal sepsis: comparison of four cephalosporins with clindamycin plus gentamicin.
Louie TJ; Onderdonk AB; Gorbach SL; Bartlett JG
J Infect Dis; 1977 Mar; 135 Suppl():S18-22. PubMed ID: 321707
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
Brook I
J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
[TBL] [Abstract][Full Text] [Related]
19. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
Brook I
J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
[TBL] [Abstract][Full Text] [Related]
20. The role of beta-lactamase and the permeability barrier on the activity of cephalosporins against members of the Bacteroides fragilis group.
Malouin F; Lamothe F
Can J Microbiol; 1987 Mar; 33(3):262-6. PubMed ID: 3105858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
